Related Experiment Video
Updated: Jun 18, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Dendritic cell vaccines for brain tumors.
1UCLA Department of Neurosurgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, CHS 74-145, Los Angeles, CA 90095-6901, USA.
Neurosurgery Clinics of North America
|December 1, 2009
Summary
Dendritic cell immunotherapy for brain tumors shows promise, with clinical trials demonstrating immune responses and improved survival. Further research is needed to optimize treatment methods and enhance efficacy for glioma patients.
Area of Science:
- Neuro-oncology
- Immunotherapy
- Cellular therapy
Background:
- Dendritic cell (DC)-based immunotherapy has emerged as a novel treatment strategy for central nervous system (CNS) tumors.
- Over the last decade, this approach has advanced from preclinical studies to Phase I/II clinical trials.
Purpose of the Study:
- To review the progress of DC-based immunotherapy for CNS tumors.
- To identify unanswered questions regarding methods and molecular mechanisms.
- To highlight the need for optimizing DC vaccination protocols and adjuvant therapies for improved glioma treatment.
Main Methods:
- Review of preclinical rodent models and safety assessments.
- Analysis of data from over 200 patients in Phase I/II clinical trials.
- Evaluation of immunologic responses and survival rates.
Main Results:
- DC-based immunotherapy has yielded measurable immunologic responses in patients with CNS tumors.
- Some studies have reported prolonged survival rates.
- The field still requires answers regarding optimal DC preparations, treatment protocols, and adjuvant regimens.
Conclusions:
- DC-based immunotherapy is a promising treatment for gliomas.
- Ongoing and future studies are crucial for refining treatment strategies and augmenting efficacy.
- Continued research is essential to optimize DC vaccination for better patient outcomes.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.